MTOR and hepatocellular carcinoma: This review examines the molecular interplay between MASLD and IR in hepatocarcinogenesis, highlighting oncogenic pathways (PI3K/Akt, mTOR), pro‐inflammatory and pro‐fibrotic mechanisms and HCC risk profiles.